Israel’s Teva has reported positive results of the Phase III trial of its Olanzapine LAI schizophrenia treatment that it has been developing with France’s Medincell. The once-a-month injections met all endpoints. It is likely to be an effective remedy without … Continue reading →

The first graduates of the SHAAR Innovation Hub (see here previously) include BeCapio, CaleeTech, Gento Gel-LR (sustained release antibiotics), Luseed Vascular, Panacea-ml, Predicta Med, Sherman Diagnostics, Snipe Medical, Sorlis, and TechnoPulm. https://www.israel21c.org/10-biomed-startups-complete-innovation-hub-on-way-to-market/ https://www.calcalistech.com/ctechnews/article/h1wa7gab0

Israel’s OrthoTreat has developed ModulX – a gel containing both a known medication plus a plant-based compound. The gel is injected directly onto the bone as a bonding agent where it strengthens the bone and improves its physiological structure. https://nocamels.com/2024/05/new-gel-jab-aims-to-help-broken-bones-heal-back-better/

Doctors at Israel’s Sheba Medical Center are using low-level lasers to treat soldiers and civilians for chronic pain caused from wounds sustained in the Oct 7 war. They stimulate mitochondria which releases ATP causing muscles to contract. Many patients experience … Continue reading →

Israel’s Healthee (see here previously) helps employers and employees select and navigate the most suitable health plan. It also connects the user with round-the-clock telehealth services that are free of charge. https://healthee.com/ https://nocamels.com/2024/05/israeli-ai-helps-us-workers-navigate-maze-of-private-healthcare/

Israel’s EndoCure (see here previously) is developing a diagnostic tool combining AI and ultrasound that would allow physicians to clearly see the tiny lesions responsible for Endometriosis. The disease causes pelvic pain and infertility for women. It can spread to … Continue reading →

Israel’s Ibex Medical Analytics (see here previously) was a bronze winner in the Diagnostic Technologies category at the 2024 Edison Awards. Ibex won the award for its Galen Breast HER2 platform, that identifies the protein responsible for the proliferation of … Continue reading →

More about the groundbreaking research of Prof. Shai Rahimipour of Israel’s Bar-Ilan University (see here previously). His Alzheimer’s disease target is a soluble amyloid protein that can be destroyed by nanoparticles that generate light when exposed to low-intensity X rays. … Continue reading →